How should we measure and report radiotherapy-induced xerostomia?

Semin Radiat Oncol. 2003 Jul;13(3):226-34. doi: 10.1016/S1053-4296(03)00033-X.

Abstract

Xerostomia is commonly measured and graded using objective measures of major salivary gland output and observer-rated toxicity grading. The separation between the different grades is somewhat ambiguous in the current toxicity grading systems. We propose a new grading system based primarily on the functional deficits associated with xerostomia. Salivary flow rates have been added as a criterion to the grading system, notwithstanding the weak correlation reported in most studies between the symptoms and objective functional measures. In addition to the observer-rated toxicity grading, recording of patient-reported quality of life, using validated instruments, is encouraged.

Publication types

  • Review

MeSH terms

  • Head and Neck Neoplasms / radiotherapy
  • Humans
  • Quality of Life
  • Radiation Injuries / diagnosis*
  • Radiation Injuries / etiology*
  • Radionuclide Imaging
  • Radiotherapy / adverse effects*
  • Salivary Glands / diagnostic imaging
  • Salivary Glands / physiopathology
  • Xerostomia / diagnosis*
  • Xerostomia / etiology*
  • Xerostomia / physiopathology